Skip to main content
Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
11.59
+0.24 (2.11%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Immatics Revenue

In the year 2025, Immatics had annual revenue of 48.27M EUR, down -69.03%. Immatics had revenue of 19.76M in the quarter ending December 31, 2025, a decrease of -64.87%.

Revenue (ttm)
48.27M EUR
Revenue Growth
-69.03%
P/S Ratio
27.42
Revenue / Employee
67,885 EUR
Employees
711
Market Cap
1.55B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202548.27M-107.57M-69.03%
Dec 31, 2024155.84M101.84M188.60%
Dec 31, 202354.00M-118.83M-68.76%
Dec 31, 2022172.83M138.07M397.17%
Dec 31, 202134.76M3.51M11.23%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ardelyx 407.32M
Immunocore Holdings 400.02M
Monte Rosa Therapeutics 123.67M
Intellia Therapeutics 67.67M
Nuvation Bio 62.90M
Nanobiotix 38.27M
Generate Biomedicines 31.89M
AtaiBeckley 4.09M
Revenue Rankings

IMTX News

More News